publication date: Dec. 21, 2010

In this issue: 

Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

NCI program announcement available, contract awards listed.

Download (PDF 469KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.